GRADE 3A FOLLICULAR LYMPHOMA
Clinical trials for GRADE 3A FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRADE 3A FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for GRADE 3A FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for untreated lymphoma patients
Disease control Recruiting nowThis study tests a combination of two drugs, acalabrutinib and obinutuzumab, in people with untreated, slow-growing lymphomas like follicular lymphoma. The goal is to see if the combo can shrink tumors and control the disease. About 49 adults will take part, and researchers will …
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New combo therapy aims to boost lymphoma treatment and cut side effects
Disease control Recruiting nowThis study tests whether combining two drugs, pirtobrutinib and mosunetuzumab, can better treat follicular lymphoma that has returned or not responded to prior therapy. About 22 adults with grade 1-3a lymphoma will receive the combination. The goal is to improve cancer remission …
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New low-dose drug shows promise for slow-growing lymphoma
Disease control Recruiting nowThis study tests whether a lower dose of the drug mosunetuzumab can safely shrink tumors in people with slow-growing B-cell lymphoma who have not had prior treatment. About 20 adults with stage II to IV follicular or marginal zone lymphoma will receive the drug and be monitored f…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 22, 2026 14:02 UTC